Central Asset Investments & Management Holdings’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Central Asset Investments & Management Holdings's MRNA Position: Q4 2021 in Review
Central Asset Investments & Management Holdings sold out of Moderna (MRNA) in Q4 2021, closing a stake of 3,960 shares — an estimated $1.52M sold.
Central Asset Investments & Management Holdings first reported a position in MRNA in Q3 2021 and held it in 1 quarter. The position peaked at $1.52M in Q3 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.
- Central Asset Investments & Management Holdings reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
- Central Asset Investments & Management Holdings sold 3,960 Moderna shares in Q4 2021, an estimated $1.52M.
- Central Asset Investments & Management Holdings first reported a position in Moderna in Q3 2021 and held it in 1 quarter.
- Central Asset Investments & Management Holdings's Moderna position peaked at $1.52M in Q3 2021.
- 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.
Based on Central Asset Investments & Management Holdings's 13F filing for Q4 2021, filed 11 Feb 2022.